Tumour initiated purinergic signalling promotes cardiomyocyte RBFOX1 degradation and cardiotoxicity from DNA damaging anticancer agentsSaymon Tejay(University of Alberta), Gopinath Sutendra(University of Alberta)Nature CommunicationsJuly 25, 202510.1038/s41467-025-62172-4Cited by 3SaveCiteExport RISWatch citationsRelated PapersGrowth differentiation factor 15 alleviates diastolic dysfunction in mice with experimental diabetic cardiomyopathy|Cell Reports|2024|14Abstract 4361033: Cardiac RBFOX1 Deficiency Enhances Glucose and Ketone Metabolism and Provides Tolerance Against Ischemia Reperfusion Injury|Circulation|2025|0